CTS Bioprocessing Acquires Sani-Tech West Companies and Rebrands as SaniSure
The companies will work to establish an operational footprint across North America and Europe that will offer customers supply chain assurance for a combined portfolio of leading solutions.
CTS Bioprocessing, a single-use bioprocessing technology company, announced on August 11, 2020 that it is acquiring Sani-Tech West Companies and rebranding from CTS Bioprocessing to SaniSure.
According to a CTS press release, the companies will work to establish an operational footprint across North America and Europe that will offer customers supply chain assurance for a combined portfolio of leading solutions, supported by a leading network of global distribution partners. The new company will provide solutions for fluid path technologies, including PharmaTainer bottles and carboys, Cap2v8 solutions, aSURE fittings, Bio-Ease clamps, Mixed4Sure closed Carboy Mixing systems, Gama stable stir bars, and a range of silicone tubing and other elastomeric solutions.
“We are excited to work with 3i and the CTS team,” said Richard Shor, founder and CEO of Sani-Tech West, in the press release. “We have a shared vision for the future, which was critical to our decision to join the group. Together, our expanded portfolio of innovative product offerings, extensive design and manufacturing capabilities, and our broadened geographic footprint will help us to become an even stronger partner to our customers.”
Source: CTS Bioprocessing
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
